Stcube
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Stcube operates across two main businesses: a cosmetics division that makes and distributes its own skincare brand, and a biopharmaceutical division developing cancer immunotherapy drugs.
Its cosmetics products reach consumers through domestic online channels, major Korean beauty retailers, and export markets including Japan and Taiwan, while its industrial lens modules are sourced and distributed to domestic corporate buyers. Listed on KOSDAQ, Korea's tech and small-cap board, the company derives the large majority of its revenue from cosmetics, with its biopharmaceutical pipeline still in clinical trials.
Summary is AI-generated and may contain errors · figures from DART filings
Its key drug candidate, Nelmastobart, is developed through a US-based subsidiary, STCube Pharmaceuticals, Inc, and targets a novel cancer biomarker described as a first-in-class therapy.
Stcube in five facts
What does Stcube do?
Stcube operates across two main businesses: a cosmetics division that makes and distributes its own skincare brand, and a biopharmaceutical division developing cancer immunotherapy drugs.
Where is Stcube listed and in which sector?
Stcube (Korean name: 에스티큐브) trades under KRX code 052020 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Industrials sector, Trading & Distribution.
How large is Stcube?
Its market capitalisation was US$380.7M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Stcube's latest annual revenue and operating profit?
For fiscal year 2025, Stcube reported revenue of US$5.3M, an operating loss of US$17.7M and a net loss of US$16.5M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was down 38.2% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.